Can Imirzalioglu

5.1k citations
101 papers · 4.0k · h-index 37

Impact in

  • Molecular Medicine top 0.1%
    • Antibiotic Resistance in Bacteria
  • Endocrinology top 0.5%
    • Enterobacteriaceae and Cronobacter Research
    • Escherichia coli research studies
    • Vibrio bacteria research studies

Papers in

  • Molecular Medicine 55
    • Antibiotic Resistance in Bacteria 55
  • Endocrinology 31
    • Enterobacteriaceae and Cronobacter Research 13
    • Escherichia coli research studies 11
Co-authors
Trinad Chakraborty (56 shared papers)Linda Falgenhauer (42 shared papers)Stephen Eliatosha Mshana (14 shared papers)Eugen Domann (21 shared papers)Torsten Hain (21 shared papers)Yancheng Yao (20 shared papers)Moritz Fritzenwanker (19 shared papers)Mariam M. Mirambo (5 shared papers)
Journals
Frontiers in Microbiology (7 papers)Journal of Clinical Microbiology (5 papers)Clinical Microbiology and Infection (5 papers)BMC Infectious Diseases (5 papers)International Journal of Antimicrobial Agents (5 papers)
Partner nations
GermanyTanzaniaSwitzerland

In The Last Decade

Can Imirzalioglu

100 papers receiving 3.9k citations

Peers

Can Imirzalioglu
Comparison fields: 5 of 123
  • Molecular Medicine 2.3k
  • Endocrinology 992
  • Applied Microbiology and Biotechnology 237
  • Pollution 879
  • Clinical Biochemistry 294
Replace Maurine A. Leverstein‐van Hall with:
Maurine A. Leverstein‐van Hall Netherlands
Fabio Arena Italy
Lorena López‐Cerero Spain
Afonso Luís Barth Brazil
David W. Wareham United Kingdom
Kang Liao China
Uma Chaudhary India
Beiwen Zheng China
Christophe de Champs France
Marie-Hélène Nicolas-Chanoine France
Can Imirzalioglu relative to Maurine A. Leverstein‐van Hall Netherlands Maurine A. Leverstein‐van Hall's profile →
Citations per field
00.5×2×3×4.2×
Maurine A. Leverstein‐van Hall · 1×
Citations per year

Countries citing papers authored by Can Imirzalioglu

Since Specialization
Citations

This map shows the geographic impact of Can Imirzalioglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can Imirzalioglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can Imirzalioglu more than expected).

Fields of papers citing papers by Can Imirzalioglu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Can Imirzalioglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can Imirzalioglu. The network helps show where Can Imirzalioglu may publish in the future.

Co-authors

The 25 scholars most cited alongside Can Imirzalioglu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Can Imirzalioglu Line = papers co-authored together Can Imirzalioglu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Colistin resistance gene mcr-1 in extended-spectrum β-lactamase-producing and carbapenemase-producing Gram-negative bacteria in Germany
The Lancet Infectious Diseases ·Linda Falgenhauer, Said-Elias Waezsada, Yancheng Yao, Can Imirzalioglu, Annemarie Käsbohrer, Uwe H. Roesler, Geovana Brenner Michael, Štefan Schwarz
2016254
2
Predictors of surgical site infections among patients undergoing major surgery at Bugando Medical Centre in Northwestern Tanzania
BMC Surgery ·Brian Caesar Mawalla, Stephen Eliatosha Mshana, Phillipo Leo Chalya, Can Imirzalioglu, William Mahalu
2011196
3
Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses
BMC Complementary and Alternative Medicine ·Christian Krawitz, Mobarak Abu Mraheil, Michael Ashley Stein, Can Imirzalioglu, Eugen Domann, Stephan Pleschka, Torsten Hain
2011154
4
Culture-Independent Identification of Pathogenic Bacteria and Polymicrobial Infections in the Genitourinary Tract of Renal Transplant Recipients
Journal of Clinical Microbiology ·Eugen Domann, George Hong, Can Imirzalioglu, Simon Turschner, Johannes Kühle, Corinna Watzel, Torsten Hain, Hamid Hossain
2003149
5
Detection and Characterization of ESBL-Producing Escherichia coli From Humans and Poultry in Ghana
Frontiers in Microbiology ·Linda Falgenhauer, Can Imirzalioglu, Kwabena Oppong, Charity Wiafe Akenten, Benedikt Hogan, Ralf Krumkamp, Sven Poppert, Vinzent Levermann
2019138
6
Multiresistant extended-spectrum β-lactamase-producing Enterobacteriaceae from humans, companion animals and horses in central Hesse, Germany
BMC Microbiology ·Judith Schmiedel, Linda Falgenhauer, Eugen Domann, Rolf Bauerfeind, Ellen Prenger‐Berninghoff, Can Imirzalioglu, Trinad Chakraborty
2014136
7
Subgrouping of ESBL-producing Escherichia coli from animal and human sources: An approach to quantify the distribution of ESBL types between different reservoirs
International Journal of Medical Microbiology ·Lars Valentin, Hannah Sharp, Katja Hille, Uwe Seibt, Jennie Fischer, Yvonne Pfeifer, Geovana Brenner Michael, Silke Nickel
2014130
8
Carbapenemase Genes among Multidrug Resistant Gram Negative Clinical Isolates from a Tertiary Hospital in Mwanza, Tanzania
BioMed Research International ·Martha Fidelis Mushi, Stephen Eliatosha Mshana, Can Imirzalioglu, Freddie Bwanga
2014125
9
Incidence and predictors of surgical site infections following caesarean sections at Bugando Medical Centre, Mwanza, Tanzania
Antimicrobial Resistance and Infection Control ·Filbert J Mpogoro, Stephen Eliatosha Mshana, Mariam M. Mirambo, Benson Richard Kidenya, Balthazar Gumodoka, Can Imirzalioglu
2014113
10
Predominance of Klebsiella pneumoniaeST14 carrying CTX-M-15 causing neonatal sepsis in Tanzania
BMC Infectious Diseases ·Stephen Eliatosha Mshana, Torsten Hain, Eugen Domann, Eligius Lyamuya, Trinad Chakraborty, Can Imirzalioglu
2013103
11
Treatment Options for Carbapenem-Resistant Gram-Negative Infections
Deutsches Ärzteblatt international ·Moritz Fritzenwanker, Can Imirzalioglu, Susanne Herold, Florian Wagenlehner, Klaus‐Peter Zimmer, Trinad Chakraborty
201898
12
Circulation of clonal populations of fluoroquinolone-resistant CTX-M-15-producing Escherichia coli ST410 in humans and animals in Germany
International Journal of Antimicrobial Agents ·Linda Falgenhauer, Can Imirzalioglu, Hiren Ghosh, Konrad Gwozdzinski, Judith Schmiedel, Katrin Gentil, Rolf Bauerfeind, Peter Kämpfer
201694
13
Environmental emission of multiresistantEscherichia colicarrying the colistin resistance genemcr-1from German swine farms
Journal of Antimicrobial Chemotherapy ·Sebastian Guenther, Linda Falgenhauer, Torsten Semmler, Can Imirzalioglu, Trinad Chakraborty, Uwe H. Roesler, Nicole Roschanski
201781
14
Multiple ST clonal complexes, with a predominance of ST131, of Escherichia coli harbouring blaCTX-M-15 in a tertiary hospital in Tanzania
Clinical Microbiology and Infection ·Stephen Eliatosha Mshana, Can Imirzalioglu, Torsten Hain, Eugen Domann, Eligius Lyamuya, Trinad Chakraborty
201177
15
The Travelling Particles: Investigating microplastics as possible transport vectors for multidrug resistant E. coli in the Weser estuary (Germany)
The Science of The Total Environment ·Jessica Song, Elanor Jongmans-Hochschulz, Norman Mauder, Can Imirzalioglu, Antje Wichels, Gunnar Gerdts
202077
16
Multiple ESBL-Producing Escherichia coli Sequence Types Carrying Quinolone and Aminoglycoside Resistance Genes Circulating in Companion and Domestic Farm Animals in Mwanza, Tanzania, Harbor Commonly Occurring Plasmids
Frontiers in Microbiology ·Jeremiah Seni, Linda Falgenhauer, Nabina Simeo, Mariam M. Mirambo, Can Imirzalioglu, Mecky Isaac Matee, Mark M. Rweyemamu, Trinad Chakraborty
201674
17
Predominance of CTX-M-15 among ESBL Producers from Environment and Fish Gut from the Shores of Lake Victoria in Mwanza, Tanzania
Frontiers in Microbiology ·Nyambura Moremi, Elizabeth V. Manda, Linda Falgenhauer, Hiren Ghosh, Can Imirzalioglu, Mecky Isaac Matee, Trinad Chakraborty, Stephen Eliatosha Mshana
201674
18
Hidden pathogens uncovered: metagenomic analysis of urinary tract infections
Andrologia ·Can Imirzalioglu, Torsten Hain, Trinad Chakraborty, Eugen Domann
200871
19
Multidrug-resistant bacteria in geriatric clinics, nursing homes, and ambulant care – Prevalence and risk factors
International Journal of Medical Microbiology ·I. M. Gruber, Ursel Heudorf, Guido Werner, Yvonne Pfeifer, Can Imirzalioglu, Hanns Ackermann, Christian Brandt, Silke M. Besier
201371
20
Predictors of the extended-spectrum-beta lactamases producing Enterobacteriaceae neonatal sepsis at a tertiary hospital, Tanzania
International Journal of Medical Microbiology ·Rehema Marando, Jeremiah Seni, Mariam M. Mirambo, Linda Falgenhauer, Nyambura Moremi, Martha Fidelis Mushi, Neema Kayange, Festo Manyama
201870

About Can Imirzalioglu

Can Imirzalioglu is a scholar working on Molecular Medicine, Endocrinology, Infectious Diseases, Pollution and Clinical Biochemistry, having authored 101 papers that have together received 4.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (55 papers), Pharmaceutical and Antibiotic Environmental Impacts (14 papers), Enterobacteriaceae and Cronobacter Research (13 papers), Escherichia coli research studies (11 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers), Genomics and Phylogenetic Studies (8 papers), Bacterial Identification and Susceptibility Testing (8 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). The work is most often cited by research in Molecular Medicine (2.3k citations), Endocrinology (992 citations), Applied Microbiology and Biotechnology (237 citations), Pollution (879 citations) and Clinical Biochemistry (294 citations). Can Imirzalioglu has collaborated with scholars based in Germany, Tanzania and Switzerland. Frequent co-authors include Trinad Chakraborty, Linda Falgenhauer, Stephen Eliatosha Mshana, Eugen Domann, Torsten Hain, Yancheng Yao, Moritz Fritzenwanker, Mariam M. Mirambo, Martha Fidelis Mushi and Uwe H. Roesler. Their work appears in journals such as Frontiers in Microbiology, Journal of Clinical Microbiology, Clinical Microbiology and Infection, BMC Infectious Diseases and International Journal of Antimicrobial Agents.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maurine A. Leverstein‐van HallBreakdown of academic impact, for papers by Fabio ArenaBreakdown of academic impact, for papers by Lorena López‐CereroBreakdown of academic impact, for papers by Afonso Luís BarthBreakdown of academic impact, for papers by David W. WarehamBreakdown of academic impact, for papers by Kang LiaoBreakdown of academic impact, for papers by Uma ChaudharyBreakdown of academic impact, for papers by Beiwen ZhengBreakdown of academic impact, for papers by Christophe de ChampsBreakdown of academic impact, for papers by Marie-Hélène Nicolas-Chanoine